OraSure Technologies, Inc. (OSUR)
USD 3.79
(-2.07%)
USD 3.79
(-2.07%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 54.07 Million USD | 1258.75% |
| 2022 | -4.66 Million USD | 59.94% |
| 2021 | -11.64 Million USD | -85.61% |
| 2020 | -6.27 Million USD | -108.16% |
| 2019 | -3.01 Million USD | -110.61% |
| 2018 | 28.42 Million USD | -29.35% |
| 2017 | 40.23 Million USD | 98.56% |
| 2016 | 20.26 Million USD | 151.49% |
| 2015 | 8.05 Million USD | 267.81% |
| 2014 | -4.8 Million USD | 60.52% |
| 2013 | -12.16 Million USD | 25.25% |
| 2012 | -16.27 Million USD | -73.12% |
| 2011 | -9.39 Million USD | -180.2% |
| 2010 | -3.35 Million USD | 61.85% |
| 2009 | -8.79 Million USD | 46.16% |
| 2008 | -16.33 Million USD | -1239.42% |
| 2007 | -1.21 Million USD | -122.32% |
| 2006 | 5.46 Million USD | -27.86% |
| 2005 | 7.57 Million USD | 658.18% |
| 2004 | -1.35 Million USD | -5.52% |
| 2003 | -1.28 Million USD | 63.69% |
| 2002 | -3.54 Million USD | 18.28% |
| 2001 | -4.33 Million USD | 66.19% |
| 2000 | -12.81 Million USD | -276.86% |
| 1999 | -3.4 Million USD | -54.55% |
| 1998 | -2.2 Million USD | 56.0% |
| 1997 | -5 Million USD | 9.09% |
| 1996 | -5.5 Million USD | 71.65% |
| 1995 | -19.4 Million USD | -22.01% |
| 1994 | -15.9 Million USD | -18.66% |
| 1993 | -13.4 Million USD | -76.32% |
| 1992 | -7.6 Million USD | -49.02% |
| 1991 | -5.1 Million USD | -54.55% |
| 1990 | -3.3 Million USD | -22.22% |
| 1989 | -2.7 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -3.35 Million USD | -143.29% |
| 2024 Q2 | -34 Thousand USD | 98.99% |
| 2023 FY | 54.07 Million USD | 1258.75% |
| 2023 Q4 | 7.74 Million USD | -28.95% |
| 2023 Q2 | -6.42 Million USD | -126.43% |
| 2023 Q1 | 24.32 Million USD | 158.82% |
| 2023 Q3 | 10.89 Million USD | 269.45% |
| 2022 Q4 | 9.39 Million USD | -32.84% |
| 2022 Q1 | -16.01 Million USD | -70.89% |
| 2022 Q2 | -21.28 Million USD | -32.94% |
| 2022 FY | -4.66 Million USD | 59.94% |
| 2022 Q3 | 13.99 Million USD | 165.73% |
| 2021 Q2 | 1.79 Million USD | -82.75% |
| 2021 Q3 | -13.01 Million USD | -823.75% |
| 2021 Q1 | 10.42 Million USD | 32.18% |
| 2021 Q4 | -9.37 Million USD | 27.99% |
| 2021 FY | -11.64 Million USD | -85.61% |
| 2020 Q1 | -8.04 Million USD | -296.96% |
| 2020 FY | -6.27 Million USD | -108.16% |
| 2020 Q2 | -9.4 Million USD | -16.84% |
| 2020 Q3 | 4.38 Million USD | 146.64% |
| 2020 Q4 | 7.88 Million USD | 79.82% |
| 2019 FY | -3.01 Million USD | -110.61% |
| 2019 Q4 | 4.08 Million USD | -68.7% |
| 2019 Q1 | -3.81 Million USD | -130.46% |
| 2019 Q3 | 13.05 Million USD | 146.96% |
| 2019 Q2 | 5.28 Million USD | 238.68% |
| 2018 Q2 | 5.55 Million USD | 1216.06% |
| 2018 FY | 28.42 Million USD | -29.35% |
| 2018 Q3 | 10.85 Million USD | 95.34% |
| 2018 Q4 | 12.51 Million USD | 15.24% |
| 2018 Q1 | -498 Thousand USD | -104.9% |
| 2017 Q2 | 6.88 Million USD | -56.61% |
| 2017 FY | 40.23 Million USD | 98.56% |
| 2017 Q4 | 10.16 Million USD | 38.83% |
| 2017 Q3 | 7.31 Million USD | 6.27% |
| 2017 Q1 | 15.87 Million USD | 124.39% |
| 2016 Q1 | 2.69 Million USD | -34.04% |
| 2016 Q2 | 4.34 Million USD | 61.13% |
| 2016 FY | 20.26 Million USD | 151.49% |
| 2016 Q3 | 6.14 Million USD | 41.27% |
| 2016 Q4 | 7.07 Million USD | 15.12% |
| 2015 FY | 8.05 Million USD | 267.81% |
| 2015 Q4 | 4.09 Million USD | 166.41% |
| 2015 Q3 | 1.53 Million USD | -43.55% |
| 2015 Q1 | -291 Thousand USD | 88.65% |
| 2015 Q2 | 2.72 Million USD | 1035.05% |
| 2014 FY | -4.8 Million USD | 60.52% |
| 2014 Q1 | -5.61 Million USD | -192.66% |
| 2014 Q4 | -2.56 Million USD | -390.59% |
| 2014 Q3 | 882 Thousand USD | -64.68% |
| 2014 Q2 | 2.49 Million USD | 144.45% |
| 2013 Q4 | 6.06 Million USD | 394.32% |
| 2013 Q3 | -2.06 Million USD | 63.06% |
| 2013 Q2 | -5.57 Million USD | 47.34% |
| 2013 FY | -12.16 Million USD | 25.25% |
| 2013 Q1 | -10.58 Million USD | -72.18% |
| 2012 Q4 | -6.15 Million USD | -110.04% |
| 2012 Q3 | -2.92 Million USD | 17.29% |
| 2012 Q2 | -3.54 Million USD | 3.07% |
| 2012 Q1 | -3.65 Million USD | -1203.24% |
| 2012 FY | -16.27 Million USD | -73.12% |
| 2011 Q3 | -4.2 Million USD | -78.21% |
| 2011 FY | -9.39 Million USD | -180.2% |
| 2011 Q4 | -280.22 Thousand USD | 93.33% |
| 2011 Q2 | -2.35 Million USD | 7.6% |
| 2011 Q1 | -2.55 Million USD | -173.96% |
| 2010 Q4 | -931.84 Thousand USD | -422.72% |
| 2010 FY | -3.35 Million USD | 61.85% |
| 2010 Q1 | -2.17 Million USD | 36.06% |
| 2010 Q2 | -535 Thousand USD | 75.41% |
| 2010 Q3 | 288.75 Thousand USD | 153.97% |
| 2009 Q1 | -1.86 Million USD | 69.86% |
| 2009 FY | -8.79 Million USD | 46.16% |
| 2009 Q2 | -5.3 Million USD | -185.17% |
| 2009 Q4 | -3.4 Million USD | -291.65% |
| 2009 Q3 | 1.77 Million USD | 133.48% |
| 2008 Q3 | -3.34 Million USD | 12.29% |
| 2008 FY | -16.33 Million USD | -1239.42% |
| 2008 Q1 | -3.01 Million USD | -108.76% |
| 2008 Q2 | -3.8 Million USD | -26.45% |
| 2008 Q4 | -6.17 Million USD | -84.75% |
| 2007 Q1 | 596.67 Thousand USD | -24.86% |
| 2007 FY | -1.21 Million USD | -122.32% |
| 2007 Q2 | 584.36 Thousand USD | -2.06% |
| 2007 Q4 | -1.44 Million USD | -50.62% |
| 2007 Q3 | -957.74 Thousand USD | -263.89% |
| 2006 Q4 | 794.12 Thousand USD | -67.97% |
| 2006 FY | 5.46 Million USD | -27.86% |
| 2006 Q2 | 1.3 Million USD | 47.0% |
| 2006 Q3 | 2.47 Million USD | 90.28% |
| 2006 Q1 | 886.34 Thousand USD | -59.38% |
| 2005 Q2 | 962 Thousand USD | -20.83% |
| 2005 FY | 7.57 Million USD | 658.18% |
| 2005 Q4 | 2.18 Million USD | -32.1% |
| 2005 Q3 | 3.21 Million USD | 234.06% |
| 2005 Q1 | 1.21 Million USD | 343.22% |
| 2004 FY | -1.35 Million USD | -5.52% |
| 2004 Q4 | -499.58 Thousand USD | -3.92% |
| 2004 Q3 | -480.75 Thousand USD | -850.49% |
| 2004 Q2 | -50.57 Thousand USD | 84.47% |
| 2004 Q1 | -325.76 Thousand USD | -186.0% |
| 2003 Q2 | -552.05 Thousand USD | 50.93% |
| 2003 Q1 | -1.12 Million USD | -813.17% |
| 2003 Q3 | 12.47 Thousand USD | 102.26% |
| 2003 Q4 | 378.78 Thousand USD | 2936.38% |
| 2003 FY | -1.28 Million USD | 63.69% |
| 2002 FY | -3.54 Million USD | 18.28% |
| 2002 Q4 | -123.19 Thousand USD | 69.3% |
| 2002 Q2 | -1.35 Million USD | 18.47% |
| 2002 Q1 | -1.66 Million USD | 33.34% |
| 2002 Q3 | -401.29 Thousand USD | 70.37% |
| 2001 Q4 | -2.49 Million USD | -22616.94% |
| 2001 Q1 | -1.23 Million USD | 85.42% |
| 2001 Q3 | -10.97 Thousand USD | 98.16% |
| 2001 Q2 | -596.86 Thousand USD | 51.56% |
| 2001 FY | -4.33 Million USD | 66.19% |
| 2000 FY | -12.81 Million USD | -276.86% |
| 2000 Q4 | -8.45 Million USD | -265.53% |
| 2000 Q3 | -2.31 Million USD | -124.22% |
| 2000 Q2 | -1.03 Million USD | -1.48% |
| 2000 Q1 | -1.01 Million USD | -75.77% |
| 1999 FY | -3.4 Million USD | -54.55% |
| 1999 Q4 | -578 Thousand USD | 35.78% |
| 1999 Q3 | -900 Thousand USD | -12.5% |
| 1999 Q2 | -800 Thousand USD | 0.0% |
| 1999 Q1 | -800 Thousand USD | 20.0% |
| 1998 Q3 | -100 Thousand USD | 66.67% |
| 1998 FY | -2.2 Million USD | 56.0% |
| 1998 Q1 | -800 Thousand USD | 27.27% |
| 1998 Q2 | -300 Thousand USD | 62.5% |
| 1998 Q4 | -1 Million USD | -900.0% |
| 1997 FY | -5 Million USD | 9.09% |
| 1997 Q4 | -1.1 Million USD | -178.57% |
| 1997 Q3 | 1.4 Million USD | 158.33% |
| 1997 Q2 | -2.4 Million USD | -20.0% |
| 1997 Q1 | -2 Million USD | -400.0% |
| 1996 FY | -5.5 Million USD | 71.65% |
| 1996 Q4 | -400 Thousand USD | -300.0% |
| 1996 Q3 | 200 Thousand USD | 110.53% |
| 1996 Q2 | -1.9 Million USD | 9.52% |
| 1996 Q1 | -2.1 Million USD | -10.53% |
| 1995 Q3 | -5.5 Million USD | -22.22% |
| 1995 Q2 | -4.5 Million USD | 10.0% |
| 1995 Q1 | -5 Million USD | -11.11% |
| 1995 FY | -19.4 Million USD | -22.01% |
| 1995 Q4 | -1.9 Million USD | 65.45% |
| 1994 FY | -15.9 Million USD | -18.66% |
| 1994 Q4 | -4.5 Million USD | 4.26% |
| 1994 Q3 | -4.7 Million USD | -20.51% |
| 1994 Q2 | -3.9 Million USD | 9.3% |
| 1994 Q1 | -4.3 Million USD | -48.28% |
| 1993 Q1 | -3.2 Million USD | -3.23% |
| 1993 FY | -13.4 Million USD | -76.32% |
| 1993 Q2 | -3.3 Million USD | -3.13% |
| 1993 Q3 | -3.8 Million USD | -15.15% |
| 1993 Q4 | -2.9 Million USD | 23.68% |
| 1992 Q4 | -3.1 Million USD | -24.0% |
| 1992 Q2 | -1.7 Million USD | 0.0% |
| 1992 Q3 | -2.5 Million USD | -47.06% |
| 1992 FY | -7.6 Million USD | -49.02% |
| 1992 Q1 | -1.7 Million USD | 5.56% |
| 1991 FY | -5.1 Million USD | -54.55% |
| 1991 Q1 | -1.4 Million USD | -75.0% |
| 1991 Q2 | -1.1 Million USD | 21.43% |
| 1991 Q3 | -1.9 Million USD | -72.73% |
| 1991 Q4 | -1.8 Million USD | 5.26% |
| 1990 Q3 | -500 Thousand USD | 58.33% |
| 1990 FY | -3.3 Million USD | -22.22% |
| 1990 Q1 | -900 Thousand USD | -28.57% |
| 1990 Q2 | -1.2 Million USD | -33.33% |
| 1990 Q4 | -800 Thousand USD | -60.0% |
| 1989 Q2 | -600 Thousand USD | -175.0% |
| 1989 FY | -2.7 Million USD | 0.0% |
| 1989 Q1 | 800 Thousand USD | 188.89% |
| 1989 Q4 | -700 Thousand USD | -40.0% |
| 1989 Q3 | -500 Thousand USD | 16.67% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 193.776% |
| AngioDynamics, Inc. | -97.71 Million USD | 155.342% |
| AtriCure, Inc. | -26.68 Million USD | 302.672% |
| Avinger, Inc. | -16.63 Million USD | 425.092% |
| Azenta, Inc. | -73.12 Million USD | 173.953% |
| BioLife Solutions, Inc. | -70.82 Million USD | 176.356% |
| The Cooper Companies, Inc. | 533.1 Million USD | 89.856% |
| Daxor Corporation | -177.07 Thousand USD | 30640.167% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 457.855% |
| Femasys Inc. | -14.5 Million USD | 472.742% |
| GlucoTrack, Inc. | -7.1 Million USD | 861.247% |
| Harvard Bioscience, Inc. | 1.89 Million USD | -2755.28% |
| Hologic, Inc. | 882.6 Million USD | 93.873% |
| ICU Medical, Inc. | 22.82 Million USD | -136.929% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 96.939% |
| KORU Medical Systems, Inc. | -10.26 Million USD | 626.574% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | -45.836% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 883.692% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 883.692% |
| Masimo Corporation | 136.5 Million USD | 60.382% |
| Microbot Medical Inc. | -9.85 Million USD | 648.747% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | -268.513% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 56.368% |
| Nephros, Inc. | -1.59 Million USD | 3494.79% |
| NovoCure Limited | -232.87 Million USD | 123.223% |
| NEXGEL, Inc. | -3.47 Million USD | 1655.335% |
| NEXGEL, Inc. | -3.47 Million USD | 1655.335% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 152.606% |
| Pro-Dex, Inc. | 7.17 Million USD | -653.924% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 224.108% |
| Predictive Oncology Inc. | -13.92 Million USD | 488.462% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | 2085.036% |
| QuidelOrtho Corporation | 139.1 Million USD | 61.122% |
| Repligen Corporation | 54.57 Million USD | 0.911% |
| Sanara MedTech Inc. | -4.21 Million USD | 1382.966% |
| STAAR Surgical Company | 28.09 Million USD | -92.473% |
| Sharps Technology, Inc. | -10.12 Million USD | 634.027% |
| Utah Medical Products, Inc. | 16.77 Million USD | -222.34% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 163.622% |
| Jin Medical International Ltd. | 2.86 Million USD | -1786.085% |